Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Mastering the correct use of Balversais the first step to ensuring efficacy and ···【more】
Release date：2024-08-27Recommended：377
In-depth analysis of the treatment of Balversa, the primary concern is its recom···【more】
Release date：2024-08-27Recommended：447
Alpelisib effectively treats patients with HR/HER2- breast cancer harboring PIK3···【more】
Release date：2024-08-26Recommended：465
As the first PI3Kα inhibitor, Alpelisib has shown significant efficacy in the tr···【more】
Release date：2024-08-26Recommended：483
Alpelisib, approved in 2019, has a unique efficacy against PIK3CA mutant breast ···【more】
Release date：2024-08-26Recommended：496
Alpelisib is the first PI3K inhibitor specifically for PIK3CA-mutated breast can···【more】
Release date：2024-08-26Recommended：449
Alpelisib was approved by the FDA in 2019 for the treatment of breast cancer pat···【more】
Release date：2024-08-26Recommended：467
Alpelisib is the first PI3Kα inhibitor to be used in combination with fulvestran···【more】
Release date：2024-08-26Recommended：511
Balversais a new target anti-cancer star, specializing in FGFR-positive cancers,···【more】
Release date：2024-08-26Recommended：416
Balversa, an innovative anti-cancer targeted drug, accurately snipes FGFR-positi···【more】
Release date：2024-08-26Recommended：439
Balversa is an innovative targeted therapy that effectively inhibits the growth ···【more】
Release date：2024-08-26Recommended：447
Balversa, a new targeted anti-cancer drug, provides new treatment hope for patie···【more】
Release date：2024-08-26Recommended：397
Telegram name: Vira
Name: LUCIUS
No.:0085253923643
